Home › Trial NCT00927147
Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer
- Trial IDNCT00927147
- StatusTerminated
- PhasePhase 1/2
- Study typeInterventional
- SponsorBoneca Corporation
- Enrollment17
- Start date2009-06
- ConditionsHead and Neck Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.